Unicycive net loss widens 147% to USD 14.55 million in FY26 first half

Reuters2026/08/12 10:32

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Unicycive posted a GAAP net loss of USD 14.55 million for the six months ended June 30, 2026, widening 147%.
Quarterly GAAP net loss narrowed to USD 1.72 million, swinging from USD 6.45 million a year earlier on higher other income.
Operating loss widened 46% to USD 10.14 million, as R&D expense rose 59% to USD 2.79 million.
General and administrative costs climbed 41% to USD 7.35 million, including a USD 0.4 million increase tied to commercial launch preparation.
FDA issued a complete response letter for the resubmitted OLC NDA on June 30, 2026, citing the same third-party manufacturing deficiencies as 2025.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Unicycive Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-088013), on August 12, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Unicycive net loss widens 147% to USD 14.55 million in FY26 first half

You may also like

Crypto prices